Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Clinical trial NCT06858319 · RECRUITING

Trial details

NCT number: NCT06858319
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Diseases Kidney Diseases, Chronic Urological Diseases Glomerulonephritis Glomerular Disease Glomerulonephritis, IGA Glomerulopathy Immunoglobulin Disease

Start date: 2025-07-28
Primary completion: 2031-06-25
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.